vTv Therapeutics Inc.
VTVT
$22.23
-$0.27-1.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 11,011.11% | 11,011.11% | 5,455.56% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 11,011.11% | 11,011.11% | 5,455.56% | -- |
| Cost of Revenue | -110.97% | -24.06% | -29.26% | -41.39% | -27.09% |
| Gross Profit | 122.44% | 33.23% | 38.25% | 48.92% | 12.86% |
| SG&A Expenses | 14.65% | 15.51% | 8.39% | 19.95% | -2.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.20% | -7.93% | -13.15% | 5.10% | 3.84% |
| Operating Income | 5.18% | 11.58% | 16.76% | -0.92% | -13.14% |
| Income Before Tax | 12.94% | 18.13% | -3.12% | -21.88% | -4.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.56% | 17.77% | -3.53% | -22.35% | -3.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -25.77% | -27.80% | -3.45% | 17.37% | -3.27% |
| Net Income | 8.83% | 14.92% | -5.51% | -23.78% | -5.67% |
| EBIT | 5.18% | 11.58% | 16.76% | -0.92% | -13.14% |
| EBITDA | 5.20% | 11.62% | 16.81% | -0.93% | -13.20% |
| EPS Basic | 56.37% | 48.39% | 17.54% | -13.80% | 6.84% |
| Normalized Basic EPS | 59.63% | 50.69% | 22.60% | -5.79% | -45.48% |
| EPS Diluted | 56.37% | 48.39% | 17.54% | -13.80% | 6.84% |
| Normalized Diluted EPS | 59.63% | 50.69% | 22.60% | -5.79% | -45.48% |
| Average Basic Shares Outstanding | 150.30% | 97.51% | 58.24% | 10.06% | 11.46% |
| Average Diluted Shares Outstanding | 150.30% | 97.51% | 58.24% | 10.06% | 11.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |